Kinza Rizwan

Baylor College of Medicine — United States

Medicine · Health Sciences

4h-index136citations15works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(13), Cancer, Lipids, and Metabolism(7), Prostate Cancer Diagnosis and Treatment(5), PARP inhibition in cancer therapy(3), DNA Repair Mechanisms(2)

Publications15 total

<scp>PARP</scp> inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer
Molecular Oncology·2025Open Access
Author response for "PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer"
2025
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis
Hepatology Communications·2024· 6 citedOpen Access
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression
npj Precision Oncology·2024· 4 citedOpen Access
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency
2024· 1 citedOpen Access
Abstract B069: SPOP loss places the prostate luminal epithelial cells at a selective disadvantage
Cancer Research·2023
Abstract 1705: <i>SPOP</i>: An essential gene for normal and prostate tumor cells
Cancer Research·2023
Supplementary Figure from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Supplementary Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Supplementary Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Data from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
Supplementary Figure from The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
2023Open Access
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
Cancer Research·2022· 38 citedOpen Access
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics
Cancer Letters·2022· 87 citedOpen Access

Frequent Co-authors

Salma Kaochar(13), Nicholas Mitsiades(10), Jenny Deng(9), Darlene G. Skapura(9), Cristian Coarfa(9), Matthew L. Freedman(9), Dallin Lowder(8), Collin McColl(8), Michael Ittmann(8), Jacob E. Berchuck(7), Elio Adib(7), Sarah Abou Alaiwi(7), Amit K. Dash(7), Jin Na Shin(7), Patricia Castro(7), Ryan Carelli(7), Elisa Benedetti(7), Sylvan C. Baca(7), Connor Bell(7), Heather M. McClure(7)